The prognostic relevance of neutrophil-to-lymphocyte ratio in infective endocarditis for heart failure patients

12 May 2024 (13:34 - 14:42)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Rafaela Fernandes

Centro Hospitalar E Universitario De Coimbra, Coimbra (Portugal)

6 More presentations in this session

Presentation thumbnail

In-hospital mortality in infective endocarditis: a score comparison

Doctor J. Gouveia Fiuza (Viseu, PT)

Abstract Slides Video

Presentation thumbnail

Highlighting the importance of risk stratification and management in infective endocarditis

Doctor A. Garcia (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Neurological complications in infective endocarditis: risk factors and outcome.

Doctor J. Mirinha Luz (Almada, PT)

Abstract Slides Video

Presentation thumbnail

The changing clinical trajectory of patients with valvular infective endocarditis during the SARS COV2 pandemic

Mrs R. Piriianu-Masgras (Bucuresti, RO)

Abstract Slides Video

Presentation thumbnail

Assessing the impact of evolving infective endocarditis epidemiology on heart failure patients: challenges and implications

Doctor R. Fernandes (Coimbra, PT)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in valvular and pulmonary 3

The Event

Event poster

Heart Failure 2024

12 May 2024 13:34 CET

You may be interested in

Congress Presentation

Blood cell counts as a source of evidence for prognostic information in patients with acute heart failure: findings from a large, single-centre study

Congress Presentation

Neutrophil to lymphocyte ratio as a predictor of left ventricle function and long-term mortality in patients after myocardial infarction.

Congress Presentation

Evaluating C-reactive protein-to-lymphocyte ratio: is there room for another biomarker in infective endocarditis?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources